Skip to main content

Table 3 Analysis of perioperative complications

From: Experience of treating high risk prostate hyperplasia patients with a HPS120 laser

Time point

Complication

Patient’s preoperative condition

  

No indwelling catheter N (%)

Indwelling catheter N (%)

No anti-coagulation treatment N (%)

Anti-coagulation treatment N (%)

Prostate volume (< 80 ml) N (%)

Prostate volume (≥ 80 ml) N (%)

 

Required electric coagulation

0

0

0

0

0

0

Perioperative period

Capsule perforation

1 (1)

0

1 (1.1)

0

1 (2.5)

0

Blood transfusion

0

0

0

0

0

0

TURP syndrome

0

0

0

0

0

0

Acute renal failure

0

1 (5)

0

1 (2.7)

0

1 (1.25)

Bladder irrigation

5 (5)

9 (45)

6 (7.1)

8 (22.2)

4 (10)

10 (12.5)

Early dysuria (3–14 days)

11 (11)

7 (35)

13 (15.5)

5 (13.9)

8 (20)

10 (12.5)

Re-catheterization

1 (1)

1 (5)

1 (1.2)

1 (2.7)

1 (2.5)

1 (1.25)

Urinary tract infection

3 (3)

2 (10)

3 (3.6)

2 (5.5)

2 (5)

3 (3.75)

Severe dysuria

1 (1)

1 (5)

2 (2.4)

0

1 (2.5)

1 (1.25)

Early postoperative (12 weeks)

Blood transfusion

0

0

0

0

0

0

Interruption of urination

1 (1)

1 (5)

1 (1.2)

1 (2.7)

2 (5)

0

Reoperation

2 (2)

2 (10)

3 (3.6)

1 (2.7)

0

3 (3.75)

Urethral stricture

0

0

0

0

0

0

Bladder neck contracture

0

0

0

0

0

0

Urinary incontinence

2 (2)

1 (5)

1 (1.2)

3 (8.3)

2 (5)

2 (2.5)

Follow up (6 months)

Interruption of urination

1 (1)

1 (5)

1 (1.2)

1 (2.7)

2 (5)

0

 

Reoperation

2 (2)

2 (10)

3 (3.6)

1 (2.7)

1 (2.5)

3 (3.75)

 

Urethral stricture

1 (1)

0

1 (1.2)

0

1 (2.5)

0

 

Bladder neck contracture

1 (1)

1 (5)

1 (1.2)

1 (2.7)

1 (2.5)

1 (1.25)

 

Urinary incontinence

2 (2)

1 (5)

1 (1.2)

3 (8.3)

2 (5)

2 (2.5)

Follow up (12–24 months)

Interruption of urination

1 (1)

1 (5)

1 (1.2)

1 (2.7)

2 (5)

0

 

Bladder neck contracture

2 (2)

2 (10)

3 (3.6)

1 (2.7)

1 (2.5)

3 (3.75)

 

Urinary incontinence

1 (1)

0

1 (1.2)

0

1 (2.5)

0

 

Bladder neck contracture

1 (1)

1 (5)

1 (1.2)

1 (2.7)

1 (2.5)

1 (1.25)

 

Urinary incontinence

2 (2)

1 (5)

1 (1.2)

3 (8.3)

2 (5)

2 (2.5)